Short description
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
Description
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders. The company's first development candidate Ecopipam, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome.
Emalex Biosciences was founded in 2018 by Jeff Aronin.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Chicago, Illinois, United States, North America
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe, Noaccess, Absolutely Noaccess, Noaccess, Noaccess
Sign in for full access
Founders
Jeff Aronin